{"id":"W4403312140","doi":"10.1016/j.jhepr.2024.101232","title":"Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"European Association for the Study of the Liver; National Institute for Health and Care Research; NIHR Imperial Biomedical Research Centre; Cancer Research UK","keywords":"Atezolizumab; Bevacizumab; Oncology; Medicine; Internal medicine; Cancer; Nivolumab; Chemotherapy; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001102408,0.0002885286,0.000464834,0.0002122724,0.00003441051,0.00004862967,0.000019635,0.0001135351,0.0004642489],"category_scores_gemma":[0.00001853143,0.0001869942,0.0001528351,0.0001233426,0.00002510446,0.0001026902,0.00002901885,0.0001335416,0.00003029014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002651447,"about_ca_system_score_gemma":0.00008005305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005609589,"about_ca_topic_score_gemma":0.0001526169,"domain_scores_codex":[0.9984466,0.00003143746,0.0004316643,0.0005704171,0.0002346897,0.0002851802],"domain_scores_gemma":[0.9993376,0.00005064048,0.00006632376,0.000366797,0.0000224702,0.0001561549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002539197,0.0003362474,0.8412343,0.0001723621,0.00009478624,0.03500357,0.0003453495,2.782137e-7,0.0001447195,0.000007174199,0.00002533996,0.1223819],"study_design_scores_gemma":[0.00228167,0.002853253,0.9610141,0.00109171,0.0002329939,0.001356073,0.00004853732,0.0004118658,0.01261135,0.0001238514,0.01764869,0.0003258838],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993785,0.002639106,0.000003605792,0.0008413831,0.0003055146,0.001028485,0.00001738116,0.0001347473,0.001244837],"genre_scores_gemma":[0.9951851,0.0002026655,0.0001548526,0.0001092447,0.00007918786,0.0005280724,0.000099472,0.00004338324,0.003598043],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.122056,"threshold_uncertainty_score":0.7625404,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03054378279230424,"score_gpt":0.3042937490793094,"score_spread":0.2737499662870052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}